Hacking goes squishy
By The Economist,
The Economist
| 09. 03. 2009
MANY of the world’s great innovators started out as hackers—people who like to tinker with technology—and some of the largest technology companies started in garages. Thomas Edison built General Electric on the foundation of an improved way to transmit messages down telegraph wires, which he cooked up himself. Hewlett-Packard was founded in a garage in California (now a national landmark), as was Google, many years later. And, in addition to computer hardware and software, garage hackers and home-build enthusiasts are now merrily cooking up electric cars, drone aircraft and rockets. But what about biology? Might biohacking—tinkering with the DNA of existing organisms to create new ones—lead to innovations of a biological nature?
The potential is certainly there. The cost of sequencing DNA has fallen from about $1 per base pair in the mid-1990s to a tenth of a cent today, and the cost of synthesising the molecule has also fallen. Rob Carlson, the founder of a firm called Biodesic, started tracking the price of synthesis a decade ago. He found a remarkably steady decline, from over $10 per base pair...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...